09.11.2019 | Original Article | Ausgabe 3/2020

Relationship between P1NP, a biochemical marker of bone turnover, and bone mineral density in patients transitioned from alendronate to romosozumab or teriparatide: a post hoc analysis of the STRUCTURE trial
- Zeitschrift:
- Journal of Bone and Mineral Metabolism > Ausgabe 3/2020